Chronic Insomnia Market to Expand Significantly by 2034, States DelveInsight Report

The Chronic Insomnia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Insomnia pipeline products will significantly revolutionize the Chronic Insomnia market dynamics.

DelveInsight's "Chronic Insomnia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Insomnia, historical and forecasted epidemiology as well as the Chronic Insomnia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Chronic Insomnia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Insomnia Market Forecast
https://www.delveinsight.com/sample-request/chronic-insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Chronic Insomnia Market Report:
• The Chronic Insomnia market size was valued approximately USD 333 million in 2021 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• A recent survey by the American Academy of Sleep Medicine indicates that 12% of Americans have been diagnosed with chronic insomnia.
• The International Classification of Sleep Disorders, 3rd edition (ICSD-3) reports that approximately 14% of the adult population in Spain suffers from chronic insomnia disorder.
• According to secondary research, insomnia is more common among middle-aged and older adults, women, and those with underlying medical or psychiatric conditions.
• Key Chronic Insomnia Companies: IDORSIA, EISAI, Janssen Research & Development, Takeda, and others
• Key Chronic Insomnia Therapies: QUVIVIQ (daridorexant), DAYVIGO (lemborexant), Seltorexant, Ramelteon and zolpidem, and others
• The Chronic Insomnia epidemiology based on gender analyzed that Chronic Insomnia is more prominent in females in comparison to males
• The Chronic Insomnia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Insomnia pipeline products will significantly revolutionize the Chronic Insomnia market dynamics.

Chronic Insomnia Overview
Chronic insomnia is a long-term sleep disorder characterized by difficulty falling asleep, staying asleep, or waking up too early, occurring at least three times a week for three months or more. It leads to daytime fatigue, impaired concentration, mood disturbances, and reduced quality of life. Causes can include stress, medical conditions, medications, or poor sleep habits.

Get a Free sample for the Chronic Insomnia Market Report:
https://www.delveinsight.com/report-store/chronic-insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Chronic Insomnia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Chronic Insomnia Epidemiology Segmentation:
The Chronic Insomnia market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Chronic Insomnia
• Prevalent Cases of Chronic Insomnia by severity
• Gender-specific Prevalence of Chronic Insomnia
• Diagnosed Cases of Episodic and Chronic Chronic Insomnia

Download the report to understand which factors are driving Chronic Insomnia epidemiology trends @ Chronic Insomnia Epidemiology Forecast
https://www.delveinsight.com/sample-request/chronic-insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Chronic Insomnia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Insomnia market or expected to get launched during the study period. The analysis covers Chronic Insomnia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Chronic Insomnia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Chronic Insomnia Therapies and Key Companies
• QUVIVIQ (daridorexant): IDORSIA
• DAYVIGO (lemborexant): EISAI
• Seltorexant: Janssen Research & Development
• Ramelteon and zolpidem: Takeda

Discover more about therapies set to grab major Chronic Insomnia market share @ Chronic Insomnia Treatment Market
https://www.delveinsight.com/sample-request/chronic-insomnia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Chronic Insomnia Market Drivers
• Increasing Prevalence
• Personalization of therapies

Chronic Insomnia Market Barriers
• Issues with diagnosis and poor knowledge
• Use of off-label drugs
• High economic burden

Scope of the Chronic Insomnia Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Chronic Insomnia Companies: IDORSIA, EISAI, Janssen Research & Development, Takeda, and others
• Key Chronic Insomnia Therapies: QUVIVIQ (daridorexant), DAYVIGO (lemborexant). Seltorexant, Ramelteon and zolpidem, and others
• Chronic Insomnia Therapeutic Assessment: Chronic Insomnia current marketed and Chronic Insomnia emerging therapies
• Chronic Insomnia Market Dynamics: Chronic Insomnia market drivers and Chronic Insomnia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Chronic Insomnia Unmet Needs, KOL's views, Analyst's views, Chronic Insomnia Market Access and Reimbursement

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.